Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Lixisenatide: Revision history

From Pharmacopedia

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

19 May 2026

  • curprev 03:1603:16, 19 May 2026 MDElliottMD talk contribs 807 bytes +807 Create Lixisenatide stub: short-acting GLP-1 receptor agonist (Adlyxin / Lyxumia, FDA 2016, withdrawn from US market 2023). Closes last redlink in Category:GLP-1 receptor agonists.